ÂÜÀòÂÒÂ×

Dr. Iris Good has a diverse range of work experience. Dr. Iris is currently an Advisor at Martlet Capital, where they began in April 2022. Dr. Iris also serves as the Chair of the Imperial College Seed Fund Investment Committee at Imperial College London since April 2020. In addition, Dr. Good is a Member of the Investment Committee at Cambridge Enterprise, starting in September 2016.

Dr. Iris has held leadership positions at various organizations, including being the Chair of Good Relations India since 2008, a Leadership Mentor at The ExCo Group since May 2022, and a Board Member at Weizmann UK since December 2021.

Dr. Good has been involved in mentoring and advisory roles within the academic community. Dr. Iris served as the Chair of the HealthTech Challenge and as a Mentor at London Business School. Dr. Iris also served as a Mentor and Judge at the Ignite, StarTech, and EnterpriseWomen programs at Cambridge Judge Business School.

Additionally, Dr. Good has served on advisory boards, including as an Advisory Board Director at Puridify from 2013 to 2015 and as an Executive Director at Sight Diagnostics from 2012 to 2014.

Dr. Iris Good obtained a Bachelor of Science (BSc) degree in Biochemistry from Ben-Gurion University of the Negev from 1982 to 1985. Dr. Iris then pursued a Master of Science (MSc) degree in Biochemistry from the Weizmann Institute of Science, completing it from 1985 to 1987. Finally, they earned a Ph.D. in Biochemistry from the Weizmann Institute of Science from 1987 to 1992. Dr. Iris Good also holds a certification in the Financial Times Non Executive Director Diploma from Pearson PLC, although the specific date of completion is not provided.